Are antineutrophil cytoplasmic antibodies a marker predictive of relapse in Wegener's granulomatosis? A prospective study.
about
Interventions for renal vasculitis in adultsCirculating angiopoietin-2 as a biomarker in ANCA-associated vasculitisCorrelation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy.Management of ANCA-associated vasculitis: Current trends and future prospectsClinical value of gallium-67 scintigraphy in assessment of disease activity in Wegener's granulomatosisCirculating markers of vascular injury and angiogenesis in antineutrophil cytoplasmic antibody-associated vasculitis.Circulating endothelial cells in relapse and limited granulomatous disease due to ANCA associated vasculitis.Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis--a meta-analysis.Monitoring proteinase 3 antineutrophil cytoplasmic antibodies for detection of relapses in small vessel vasculitis.Relationship between markers of platelet activation and inflammation with disease activity in Wegener's granulomatosis.Serum proteins reflecting inflammation, injury and repair as biomarkers of disease activity in ANCA-associated vasculitis.Pregnancy complicating Wegener's granulomatosisBiomarkers in ANCA-associated vasculitis.Conventional induction and maintenance treatment of Antineutrophil cytoplasmic antibodies-associated vasculitis - still of value for our patients?Factors Determining the Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3.Make the grade for Wegener's granulomatosis after kidney transplantation.Targeted proteomics reveals promising biomarkers of disease activity and organ involvement in antineutrophil cytoplasmic antibody-associated vasculitis
P2860
Q24187038-96705579-99B8-4256-A3E4-DDE364204E86Q28732725-C60E5B47-5578-40BE-93BB-6B86D58161ADQ33844947-7737178C-71FF-4708-835E-5F1BFE709566Q33947599-CB2324FA-C4DF-4AFB-A9AE-491295990FD6Q35552905-95CFE93A-A65A-49D0-803F-9C156C9A3D47Q35583154-C67EB7D2-A49F-4D3B-A87B-3CA37069AA8CQ35636746-CB5341D2-7C4C-42D4-9AF3-D3C659A71570Q35747186-4EAF87B6-2C64-4560-875B-106569D38AD4Q35923750-E5CAD06E-4A9D-440F-B878-52ADE9B987BEQ36843060-32B97FC8-AEAF-41C5-82AA-681AF39AA848Q37170453-92B9CDC0-940D-47BC-9442-CD96EEF3AE5FQ37186283-3B6B74CA-F4A3-475C-ABDD-F5EECBFF6A9EQ38129720-6559C3F2-4075-4464-9822-486BCF72B178Q38543360-91A162B8-68DE-432A-BC43-242DD9380020Q39993490-79ECC46B-923E-4DA5-9BD3-C6D150D2F479Q40320143-2DBCB199-A92A-4619-835D-A7429F03F204Q41992856-CD96CF8E-12EE-4F56-9913-0CE2BD62740A
P2860
Are antineutrophil cytoplasmic antibodies a marker predictive of relapse in Wegener's granulomatosis? A prospective study.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Are antineutrophil cytoplasmic ...... omatosis? A prospective study.
@ast
Are antineutrophil cytoplasmic ...... omatosis? A prospective study.
@en
type
label
Are antineutrophil cytoplasmic ...... omatosis? A prospective study.
@ast
Are antineutrophil cytoplasmic ...... omatosis? A prospective study.
@en
prefLabel
Are antineutrophil cytoplasmic ...... omatosis? A prospective study.
@ast
Are antineutrophil cytoplasmic ...... omatosis? A prospective study.
@en
P2093
P356
P1433
P1476
Are antineutrophil cytoplasmic ...... omatosis? A prospective study.
@en
P2093
Cordier JF
Guillevin L
P304
P356
10.1093/RHEUMATOLOGY/40.2.147
P577
2001-02-01T00:00:00Z